Form D — Voxcell BioInnovation Inc.

0002041826-26-000003 · filed Sep 1, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $2,200,676
Reported amount sold: $2,200,676
Minimum investment: $0
Investors: 31
Sales commission: $0
Finders' fees: $0

Issuer

Name: Voxcell BioInnovation Inc.
CIK: 2041826
Entity: Corporation
Jurisdiction: BRITISH COLUMBIA, CANADA
Year incorporated: —
Address: 300-637 BAY STREET
VICTORIA, A1 V8T 5L2
Phone: 672-974-8850

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Karolina Papera Valente · Executive Officer

Victoria, A1 Find on LinkedIn ↗
Thomas Neumann · Director

Seattle, WA Find on LinkedIn ↗
Marie-Helene Raigneau · Director

Chateauguay, A8 Find on LinkedIn ↗
Jessica Miller · Director

Toronto, A6 Find on LinkedIn ↗
Mark Miller · Director

Oakville, A6 Find on LinkedIn ↗

Other filings from this issuer

Form D — Mar 24, 2025 — 0002041826-25-000001

View the original filing on SEC EDGAR ↗